Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

195 projects found matching your search criteria :

  1. Activation of endogenous pronociceptive mechanisms of opioid system as an important factors in the development of neurop...

    Call: MAESTRO 3 , Panel: NZ4

    Principal investigator: prof. Barbara Elżbieta Przewłocka

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  2. The influence of the serotonergic system on the regulation of liver CYP activity in hepatocellular carcinoma

    Call: SONATA 4 , Panel: NZ4

    Principal investigator: dr Marta Ewa Kot

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  3. The role of the brain serotonergic system in the expression and activity of liver cytochrome P450.

    Call: PRELUDIUM 4 , Panel: NZ7

    Principal investigator: dr Marta Anna Rysz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  4. Research on influence of antidepressant drugs on serum and brain levels of neurotrophins in rats, affected by the time d...

    Call: OPUS 4 , Panel: NZ4

    Principal investigator: dr Maciej Sławomir Kuśmider

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  5. The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants.

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  6. Effect of caffeine on neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse brain.

    Call: PRELUDIUM 6 , Panel: NZ7

    Principal investigator: Anna Maria Górska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. The influence of 5-HT7 and NMDA receptor ligands with possible antidepressive properties on the activity of rat dorsal r...

    Call: OPUS 6 , Panel: NZ4

    Principal investigator: prof. Grzegorz Władysław Hess

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  8. Involvement of cyclooxygenase 2 in antidepressant-like effects of metabotropic glutamatergic receptors group I.

    Call: SONATA 7 , Panel: NZ7

    Principal investigator: dr Katarzyna Małgorzata Stachowicz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  9. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  10. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  11. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Call: OPUS 22 , Panel: NZ6

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  12. Brain GABAB receptors as determinants of obesity phenotypes: evaluation of adolescent female and male rats

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: prof. Małgorzata Maria Filip

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  13. Translational and interdisciplinary investigation of phenotypes of reinforcement sensitivity as predictors of the respon...

    Call: OPUS 22 , Panel: HS6

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  14. The developmental changes in the endogenous opioid system associated with altered sensitivity to reward during adolescen...

    Call: PRELUDIUM 21 , Panel: NZ4

    Principal investigator: Klaudia Weronika Misiołek

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  15. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  16. Impact of maternal monosaccharide diet on dams and offspring hippocampus development.

    Call: PRELUDIUM 22 , Panel: NZ1

    Principal investigator: Kacper Karol Witek

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  17. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  18. The evaluation of the efficacy of alpha7 nicotinic acetylcholine receptor ligands in rat models of autism

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Nikiforuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  19. Impact of early-life stress on maturation, permeability of blood brain-barrier and neuroinflammatory processes activatio...

    Call: PRELUDIUM 12 , Panel: NZ4

    Principal investigator: Anna Katarzyna Solarz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  20. Sensitivity to negative feedback as a cognitive biomarker of depression in an animal model

    Call: OPUS 12 , Panel: NZ4

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  21. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic st...

    Call: HARMONIA 9 , Panel: NZ7

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  22. New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 ...

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: dr Klaudia Kwiatkowski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  23. The role of cognitive bias in individual vulnerability to to the transition from controlled use to uncontrolled abuse of...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  24. Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st...

    Call: OPUS 16 , Panel: NZ2

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. The role of epigenetic readers from BET family in the emergence and treatment of schizophrenia-like abnormalities in a n...

    Call: OPUS 16 , Panel: NZ4

    Principal investigator: prof. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  26. The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

    Call: SONATA 9 , Panel: NZ4

    Principal investigator: dr Ewelina Joanna Rojewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  27. The impact of early-life stress (maternal separation) and fluctuation in corticosterone levels during adolescence on pre...

    Call: PRELUDIUM 9 , Panel: NZ4

    Principal investigator: Iwona Magdalena Majcher-Maślanka

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  28. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  29. Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

    Call: HARMONIA 7 , Panel: NZ7

    Principal investigator: Sabina Marta Podlewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  30. The effect of the metabotropic glutamatergic receptor ligands on potentiating the antidepressant-like actvity of scopola...

    Call: PRELUDIUM 10 , Panel: NZ7

    Principal investigator: Karolina Sylwia Podkowa

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  31. Search for new targets for an effective therapy of neuropathic pain and enhancement of opioids effects basing on the exa...

    Call: OPUS 11 , Panel: NZ4

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  32. Characterisation of the orbitofrontal cortex dopamine D1 and D2 receptors' influence on rat's cognitive flexibility and ...

    Call: PRELUDIUM 11 , Panel: NZ4

    Principal investigator: Michał Dariusz Rychlik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  33. Effects of chosen chemokines on the activity and synaptic transmission in central and basolateral complex of the amygdal...

    Call: PRELUDIUM 11 , Panel: NZ4

    Principal investigator: Joanna Ewa Sowa

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  34. The role of halogen bonding in interaction of ligands with SERT.

    Call: SONATA 11 , Panel: NZ7

    Principal investigator: dr Jakub Staroń

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  35. Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Katarzyna Popiołek-Barczyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  36. Evaluation of molecular mechanisms of neuroprotective action of dental pulp stromal cells in an ex vivo organotypic mode...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: dr Natalia Helena Bryniarska-Kubiak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  37. In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological ...

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Piotr Chmielarz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  38. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

    Call: SONATINA 4 , Panel: NZ7

    Principal investigator: Katarzyna Anna Szczepańska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  39. Influence of modified maternal diet on the phenotype of offspring: behavioral and molecular correlations

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Kinga Eryka Gawlińska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  40. Zinc deficient diet as a trigger for treatment-resistant depression in chronically stressed mice. Understanding the mech...

    Call: OPUS 19 , Panel: NZ5

    Principal investigator: dr hab. Bernadeta Szewczyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  41. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  42. seQinspector - genome-wide analysis of gene transcription regulation mechanisms

    Call: PRELUDIUM 1 , Panel: NZ2

    Principal investigator: dr Marcin Piechota

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  43. The effects of ligands of the alpha7 nicotinic acetylcholine receptors on complex cognitive processes and social behavio...

    Call: PRELUDIUM 8 , Panel: NZ7

    Principal investigator: Agnieszka Teresa Potasiewicz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  44. Neural substrates of decision making under risk and uncertainty: role of phasic activity of dopamine neurons

    Call: PRELUDIUM 8 , Panel: NZ4

    Principal investigator: Przemysław Eligiusz Cieślak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  45. The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cogni...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Paulina Agnieszka Cieślik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk